PharmChem (PCHM) Short Interest Ratio & Short Volume $3.15 0.00 (0.00%) (As of 11/21/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartDividendEarningsShort Interest PharmChem Short Interest DataPharmChem (PCHM) has a short interest of 100 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 1,399 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$340.00Short Interest Ratio0.0 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares4,650,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume0 sharesAverage Trading Volume1,399 sharesToday's Volume Vs. Average0% Short Selling PharmChem? Sign up to receive the latest short interest report for PharmChem and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPCHM Short Interest Over TimePCHM Days to Cover Over TimePCHM Percentage of Float Shorted Over Time Ad Behind the MarketsCan Trump Make Housing Great Again?Trump won. But can he undo the damage the Democrats have inflicted on this nation? Under Biden, inflation soared 20%... Which could be the final blow for the American Dream - even with Trump in office.Take these three steps today to protect your retirement from Biden's legacy >>> PharmChem Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024100 shares $340.00 No ChangeN/A0 $3.40 10/15/2024100 shares $360.00 No ChangeN/A0 $3.60 8/15/2024200 shares $680.00 No ChangeN/A0.1 $3.40 7/31/2024200 shares $637.98 No ChangeN/A0.3 $3.19 6/30/2024100 shares $365.00 No ChangeN/A0 $3.65 5/31/2024100 shares $300.00 No ChangeN/A0.2 $3.00 Get the Latest News and Ratings for PCHM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PharmChem and its competitors with MarketBeat's FREE daily newsletter. 5/15/2024100 shares $260.00 No ChangeN/A0 $2.60 2/15/2024100 shares $300.00 No ChangeN/A0.2 $3.00 1/15/2024100 shares $252.00 No ChangeN/A0.5 $2.52 12/15/2023200 shares $510.00 +100.0%N/A0 $2.55 11/30/2023100 shares $255.00 -66.7%N/A0 $2.55 11/15/2023300 shares $780.00 +200.0%N/A0.2 $2.60 10/31/2023100 shares $275.00 No ChangeN/A0.3 $2.75 10/15/2023100 shares $260.00 No ChangeN/A0 $2.60 9/30/2023100 shares $261.00 No ChangeN/A0 $2.61 9/15/2023100 shares $255.00 No ChangeN/A0.1 $2.55 8/31/2023100 shares $260.00 No ChangeN/A0 $2.60 6/30/2023100 shares $255.00 No ChangeN/A0 $2.55 4/15/2023300 shares $905.85 +50.0%N/A0.1 $3.02 3/31/2023200 shares $548.76 No ChangeN/A0.1 $2.74 2/15/20231,900 shares $5,890.00 -45.7%N/A1.1 $3.10 1/31/20233,500 shares $9,450.00 No ChangeN/A7 $2.70 12/15/2022100 shares $211.00 No ChangeN/A0 $2.11 8/31/2022700 shares $1,995.00 -12.5%N/A0.9 $2.85 8/15/2022800 shares $2,048.00 No ChangeN/A0.1 $2.56 6/15/2022200 shares $580.00 No ChangeN/A0 $2.90 4/15/2022200 shares $858.00 No ChangeN/A0.1 $4.29 2/28/2022900 shares $4,275.00 -52.6%N/A0.3 $4.75 2/15/20221,900 shares $9,310.00 +1,800.0%N/A0.8 $4.90 1/31/2022100 shares $500.00 No ChangeN/A0 $5.00 11/30/2021100 shares $450.00 No ChangeN/A0 $4.50 11/15/2021100 shares $468.00 No ChangeN/A0 $4.68 9/30/2021100 shares $470.00 No ChangeN/A0 $4.70 8/31/2021100 shares $548.00 -75.0%N/A0 $5.48 8/13/2021400 shares $1,940.00 +300.0%N/A0 $4.85 7/30/2021100 shares $550.00 No ChangeN/A0 $5.50 6/30/2021100 shares $485.00 -75.0%N/A0 $4.85 6/15/2021400 shares $1,900.00 +300.0%N/A0 $4.75 5/28/2021100 shares $455.00 -99.7%N/A0 $4.55 5/14/202133,200 shares $151,060.00 +4,642.9%N/A0.2 $4.55Can Trump Make Housing Great Again? (Ad)Trump won. But can he undo the damage the Democrats have inflicted on this nation? Under Biden, inflation soared 20%... Which could be the final blow for the American Dream - even with Trump in office.Take these three steps today to protect your retirement from Biden's legacy >>> 4/30/2021700 shares $3,213.00 No ChangeN/A0 $4.59 1/29/2021400 shares $1,800.00 No ChangeN/A0.1 $4.50 1/15/2021300 shares $1,143.00 No ChangeN/A0.2 $3.81 12/31/2020300 shares $1,140.00 No ChangeN/A0.2 $3.80 12/15/2020300 shares $1,200.00 No ChangeN/A0.2 $4.00 10/30/2020100 shares $380.00 No ChangeN/A0 $3.80 PCHM Short Interest - Frequently Asked Questions What is PharmChem's current short interest? Short interest is the volume of PharmChem shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 100 shares of PCHM short. Learn More on PharmChem's current short interest. How does PharmChem's short interest compare to its competitors? Here is how the short interest of companies compare to PharmChem: Burning Rock Biotech Limited (0.99%), Enzo Biochem, Inc. (1.31%), American Shared Hospital Services (0.79%), OpGen, Inc. (0.19%), Psychemedics Co. (0.31%), BioNexus Gene Lab Corp. (1.20%), Aclarion, Inc. (4.50%), Fresh2 Group Limited (0.72%), Zicix Co. (0.02%), MDxHealth SA (0.07%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short PharmChem stock? Short selling PCHM is an investing strategy that aims to generate trading profit from PharmChem as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against PharmChem? A short squeeze for PharmChem occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PCHM, which in turn drives the price of the stock up even further. How often is PharmChem's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PCHM, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Burning Rock Biotech Short Interest Data Enzo Biochem Short Interest Data American Shared Hospital Services Short Interest Data OpGen Short Interest Data Psychemedics Short Interest Data BioNexus Gene Lab Short Interest Data Aclarion Short Interest Data Fresh2 Group Short Interest Data Zicix Short Interest Data First Choice Healthcare Solutions Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:PCHM) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PharmChem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PharmChem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.